Wieliczko Monika
Warsaw, 01-949, Poland
NCT Number: NCT05861700
Hyperphosphatemia is still an unresolved problem among hemodialysis patients and significantly increases the risk of death from cardiovascular diseases. Research to date has not answered the question of whether dialysate bicarbonate concentration profiling can improve phosphate removal and its concentration without negative impact on the acid-base balance. This study addressed this issue.
Twenty stable hemodialysis patients will enroll to a four-week study during which different dialysate bicarbonate concentration profiles will be used each week. Each patient will undergo the following profiles (one-week periods): Treatment A - stable dialysate bicarbonate concentration Dbic 35 mmol/L during the whole HD session, Treatment B - Dbic 35 mmol/L for the first two hours and Dbic 30 mmol/L for the next two hours and Treatment C - the opposite mid-HD change Dbic from 30 to 35 mmol/L and one week wash-out period between Treatment B and C. We will collect blood samples each hour during the session and one hour after HD completion.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Warsaw, 01-949, Poland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A change Dbic in a middle of hemodialysis
A change Dbic in a middle of hemodialysis
Time frame: 4 weeks
The blood phosphorus concentration change in hemodialysis patient using dialysate bicarbonate profiling
Time frame: 4 weeks
Medical University of Warsaw
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03256838
Chronic Disease, Disease Attributes
Kaohsiung City, Taiwan
View Trial DetailsNCT02435017
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT04229069
Acid-Base Balance Disorder, Acid-Base Imbalance
View Trial DetailsNCT01880281
Acid Base Disorder, Acid-Base Imbalance
Lausanne, Canton of Vaud, Switzerland
View Trial Details